Amrutanjan Health Care Limited · NSE:AMRUTANJAN
Amrutanjan Health Care — Q1 FY21 Earnings Presentation
12 slides from Amrutanjan Health Care's earnings presentation, Aug 13, 2020
Slide 1: Stock exchange cover letter for investor presentation
AHCL/ SE/ 24 /2020-21 August 13 2020 The National Stock Exchange of IndiaLimited BSE Limited “Exchange Plaza”, C-1, Block G Department of Corporate Services Bandra-Kurla Complex, Bandra (E) 1° Floor, Mumbai 400 051 P.J. Towers, Dalal Street, Mumbai 400 001 Symbol : AMRUTANJAN Scrip Code: 590006 Dear
Slide 2: Amrutanjan Health Care Limited Investor Presentation – Quarter Ended 30th June 2020
Amrutanjan Health Care Limited Investor Presentation – Quarter Ended 30th June 2020 Date: 13th August 2020
Slide 3: Contents
Contents a. Business Update b. Q1 FY21 Performance c. Way Forward Investor Presentation | Quarter Ended 30th June 2020
Slide 4: Business Update
Business Update Investor Presentation | Quarter Ended 30th June 2020
Slide 5: Our Business during COVID
Our Business during COVID • Despite restrictions for field force during lockdown, our wholesale channel was picking up. This shows our Brand strength. • Consumers’ current preference of Balms over Tablets remains to be seen for its longevity. • Demand is growing for our core products – Balms & Women
Slide 6: Q1 FY21 Performance
Q1 FY21 Performance Investor Presentation | Quarter Ended 30th June 2020
Slide 7: Financials – Q1 FY21
Financials – Q1 FY21 (Rs. in Crores) Gross Sales Profit Before Tax Profit After Tax 51.17 8.66 6.43 49.26 (0.91) (0.70) Q1 FY21 Q1 FY20 Q1 FY21 Q1 FY20 Q1 FY21 Q1 FY20 Growth: 3.88% Investor Presentation | Quarter Ended 30th June 2020
Slide 8: Financials – Q1 FY21 – OTC Division
Financials – Q1 FY21 – OTC Division (Rs. in Crores) Gross Sales - OTC Notes: 47.09 • OTC sales has grown by 19.97% 39.25 during the quarter even though April sales was affected due to Covid 19 lockdown Q1 FY21 Q1 FY20 • Key raw material prices including Growth: 19.97% Menthol are lower when compared
Slide 9: Financials – Q1 FY21 – Beverage Division
Financials – Q1 FY21 – Beverage Division (Rs. in Crores) Gross Sales - Beverages 9.46 Notes: 3.98 • Gross Margin has improved by 443 basis points when compared to Q1 FY20 mainly Q1 FY21 Q1 FY20 due to product mix. Growth: -57.93% • Advertisement spend is maintained at the same level - Gross Sales -
Slide 10: Way Forward
Way Forward Investor Presentation | Quarter Ended 30th June 2020
Slide 11: Way Forward
Way Forward We remain focused on executing our priorities: • Get back the lost revenue of Q4 FY20 due to Covid 19 lockdown • Expanding distribution • Expanding E-Commerce business • Costs control Investor Presentation | Quarter Ended 30th June 2020
Slide 12: Investor Presentation | Quarter Ended 30th June 2020
Investor Presentation | Quarter Ended 30th June 2020
Amrutanjan Health Care — Q1 FY21 Earnings Presentation on 6ix